---

---

tags : Positive    crawled date : 2021 - 09 - 20   

save search

---

CUMULUS MEDIA ADDS SENIOR POSITIONS FOR MULTI-PLATFORM CONTENT DEVELOPMENT
Published: 2021-09-20 (Crawled : 16:00) - cumulusmedia.com
CMLS | News | $2.98 6.81% 6.38% 61K |

Consumer Services

| -69.55% | O: 0.31% H: 2.44% C: 0.41%
media positive platform

---

Continuous Positive Airway Pressure (CPAP) Devices Market analysis in Health Care Equipment Industry | $ 1.08 Bn Growth Expected During 2021-2025 | 17,000+ Technavio Research Reports
Published: 2021-09-20 (Crawled : 14:15) - prnewswire.com
RMD | $178.85 0.7% 0.0% 1.2M |

Health Technology

| -37.45% | O: -1.35% H: 1.66% C: 0.76%
positive growth device research

---

Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Published: 2021-09-20 (Crawled : 14:00) - globenewswire.com
MMSI | $72.06 1.51% 1.48% 530K |

Health Technology

| 0.53% | O: -1.65% H: 1.76% C: 1.56%
positive results positive results

---

Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.305 -8.1% -8.81% 2.6M |

Health Technology

| -85.35% | O: -4.25% H: 3.62% C: -1.17%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -5.75% | O: 0.14% H: 1.4% C: 0.04%
prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b

---

Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -47.69% | O: -2.97% H: 2.56% C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical

---

Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K |

Health Technology

| -20.61% | O: 68.6% H: 26.98% C: 26.14%
covid phase 2 positive antibody biotech iot covid-19

---

Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published: 2021-09-20 (Crawled : 12:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0 |

Health Technology

| -65.56% | O: 0.78% H: 11.36% C: 3.1%
phase 2 lung cancer positive results cancer topline

---

BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
BYSI | $1.8 -2.21% 80K |

Health Technology

| -91.56% | O: -19.1% H: 7.65% C: -16.07%
positive phase 3 plinabulin

---

BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncology (ESMO) 2021 Congress
Published: 2021-09-20 (Crawled : 12:00) - globenewswire.com
BYSI | $1.8 -2.21% 80K |

Health Technology

| -91.56% | O: -19.1% H: 7.65% C: -16.07%
lung cancer europe positive cancer phase 3 plinabulin

---

Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
SYBX | $1.815 -0.82% -0.83% 54K |

Health Technology

| -40.82% | O: 11.39% H: 14.77% C: 5.4%
phase 2 positive phenylketonuria

---

Equinox Gold Announces Positive Pre-Feasibility Study for Aurizona Expansion and 73% Increase to Mineral Reserves
Published: 2021-09-20 (Crawled : 11:00) - prnewswire.com
EQX | $6.0 2.39% 0.0% 1.8M |

Non-Energy Minerals

| -14.53% | O: 0.85% H: 0.0% C: -1.27%
expansion positive

---

Farmland Partners Inc. Shares Impact from Hurricanes Ida and Nicholas (No Significant Damage) and Strong Positive Lease Renewal Trends
Published: 2021-09-20 (Crawled : 11:00) - prnewswire.com
FPI 4 | $10.75 1.61% -0.93% 360K |

Finance

| -15.09% | O: -1.66% H: 1.37% C: -0.16%
positive

---

Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.02% | O: -1.35% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -76.6% | O: -8.02% H: 3.64% C: -0.64%
covid positive results topline children vaccine trial

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---